Status: Approved
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Hemorrhage Phase 4 ClinicalTrials
Hemorrhage; Wounds and Injuries Phase 2 ClinicalTrials
Blood Loss, Surgical Phase 3 ClinicalTrials
Coronary Artery Disease; Hemorrhage Phase 2 ClinicalTrials
Blood Coagulation Disorders; Hemostatic Disorders Phase 1/Phase 2 ClinicalTrials
Hemorrhage; Scoliosis Phase 3 ClinicalTrials
Heart Diseases Phase 3 ClinicalTrials
Pancreatic Neoplasms Phase 4 ClinicalTrials
CONTENTS